These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 33169003)

  • 1. Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing.
    Jacob F; Ming GL; Song H
    Nat Protoc; 2020 Dec; 15(12):4000-4033. PubMed ID: 33169003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.
    Jacob F; Salinas RD; Zhang DY; Nguyen PTT; Schnoll JG; Wong SZH; Thokala R; Sheikh S; Saxena D; Prokop S; Liu DA; Qian X; Petrov D; Lucas T; Chen HI; Dorsey JF; Christian KM; Binder ZA; Nasrallah M; Brem S; O'Rourke DM; Ming GL; Song H
    Cell; 2020 Jan; 180(1):188-204.e22. PubMed ID: 31883794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organoids: A Platform Ready for Glioblastoma Precision Medicine?
    Jin WL; Jin MZ; Tu YY
    Trends Cancer; 2020 Apr; 6(4):265-267. PubMed ID: 32209439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion.
    Darrigues E; Zhao EH; De Loose A; Lee MP; Borrelli MJ; Eoff RL; Galileo DS; Penthala NR; Crooks PA; Rodriguez A
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma.
    Brown CE; Aguilar B; Starr R; Yang X; Chang WC; Weng L; Chang B; Sarkissian A; Brito A; Sanchez JF; Ostberg JR; D'Apuzzo M; Badie B; Barish ME; Forman SJ
    Mol Ther; 2018 Jan; 26(1):31-44. PubMed ID: 29103912
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Brakel BA; Chokshi CR; Salim SK; Venugopal C; Singh S
    STAR Protoc; 2021 Dec; 2(4):100920. PubMed ID: 34761232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive Transfer of IL13Rα2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma.
    Pituch KC; Miska J; Krenciute G; Panek WK; Li G; Rodriguez-Cruz T; Wu M; Han Y; Lesniak MS; Gottschalk S; Balyasnikova IV
    Mol Ther; 2018 Apr; 26(4):986-995. PubMed ID: 29503195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of the alpha
    Cobb DA; de Rossi J; Liu L; An E; Lee DW
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35210306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma.
    Goff SL; Morgan RA; Yang JC; Sherry RM; Robbins PF; Restifo NP; Feldman SA; Lu YC; Lu L; Zheng Z; Xi L; Epstein M; McIntyre LS; Malekzadeh P; Raffeld M; Fine HA; Rosenberg SA
    J Immunother; 2019 May; 42(4):126-135. PubMed ID: 30882547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Testing of CAR T Cells in a Patient-Derived Xenograft Model of Glioblastoma.
    Tatari N; Maich WT; Salim SK; Mckenna D; Venugopal C; Singh S
    STAR Protoc; 2020 Dec; 1(3):100174. PubMed ID: 33377068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for Glioblastoma: Adoptive T-cell Strategies.
    Choi BD; Maus MV; June CH; Sampson JH
    Clin Cancer Res; 2019 Apr; 25(7):2042-2048. PubMed ID: 30446589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.
    Sahin A; Sanchez C; Bullain S; Waterman P; Weissleder R; Carter BS
    PLoS One; 2018; 13(7):e0199414. PubMed ID: 29975720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAR T-Cell Therapies in Glioblastoma: A First Look.
    Migliorini D; Dietrich PY; Stupp R; Linette GP; Posey AD; June CH
    Clin Cancer Res; 2018 Feb; 24(3):535-540. PubMed ID: 29158268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of Cytotoxic Potential of CAR-T Cells in Co-cultivation Assays.
    Nacasaki Silvestre R; Moço PD; Picanço-Castro V
    Methods Mol Biol; 2020; 2086():213-222. PubMed ID: 31707679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol to optimize the biobanking of ovarian cancer organoids by accommodating patient-specific differences in stemness potential.
    Trillsch F; Czogalla B; Kraus F; Burges A; Mahner S; Kessler M
    STAR Protoc; 2023 Sep; 4(3):102484. PubMed ID: 37585293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges.
    Bagley SJ; Desai AS; Linette GP; June CH; O'Rourke DM
    Neuro Oncol; 2018 Oct; 20(11):1429-1438. PubMed ID: 29509936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme.
    Marei HE; Althani A; Afifi N; Hasan A; Caceci T; Pozzoli G; Cenciarelli C
    Cancer Med; 2021 Aug; 10(15):5019-5030. PubMed ID: 34145792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric Antigen Receptor T-Cell Therapy: Updates in Glioblastoma Treatment.
    Feldman L; Brown C; Badie B
    Neurosurgery; 2021 May; 88(6):1056-1064. PubMed ID: 33575786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival of chimeric antigen receptor-engineered T (CAR-T) and tumor-specific T cells caused by anti-programmed cell death protein 1 single-chain variable fragment-producing CAR-T cells.
    Nakajima M; Sakoda Y; Adachi K; Nagano H; Tamada K
    Cancer Sci; 2019 Oct; 110(10):3079-3088. PubMed ID: 31432594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity.
    Torres Chavez A; McKenna MK; Canestrari E; Dann CT; Ramos CA; Lulla P; Leen AM; Vera JF; Watanabe N
    J Immunother Cancer; 2019 Nov; 7(1):330. PubMed ID: 31779709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.